tyna moore glp 1 GLP-1s are NOT the answer! Dr. Tyna Moore: The Truth

Biomapro Bioma New York City, June 24, 2025 (GLOBE NEWSWIRE) -- In the world of modern health, one truth stands out: your gut is at the core of almost everything

Herein, we successfully switched a patient with acromegaly from a dipeptidyl peptidase-4 (DPP-4) inhibitor to a glucagon-like peptide-1 (GLP-1) analog due to pasireotide-induced deterioration of glycemic control, and we examined the underlying mechanism for glycemic control

Callus to schedule your appointment877.588.4646

Use of glucagon-like peptide 1 agonists for weight loss compared with bupropion-naltrexone was associated with an increased risk for pancreatitis, gastroparesis and bowel obstruction but not biliary disease, researchers reported in JAMA

Lipedema, una condicin crnica de grasa que afecta principalmente a mujeres, se caracteriza por una acumulacin anormal de grasa en las caderas, muslos y